nach oben

Erschienen in:

01.04.2011 | Research Article

Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV)

verfasst von: José Vieira de Spíndula-Filho, Aparecido Divino da Cruz, Angélica Ferreira Oton-Leite, Aline Carvalho Batista, Cláudio Rodrigues Leles, Rita de Cássia Gonçalves Alencar, Vera Aparecida Saddi, Elismauro Francisco Mendonça

Erschienen in: Tumor Biology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Human papillomavirus (HPV) has been cited as a possible initiating agent in the pathogenesis of oral cancer. However, the literature tends to be both controversial and inconclusive about the prevalence of HPV and its potential for proliferation in oral squamous cell carcinoma (SCC). The aim of this study was to investigate the cellular proliferation and the presence of HPV in SCC and verrucous carcinoma (VC). Forty-seven samples of SCC were selected and divided into three groups: 39 SCC, 8 VC, and 9 of normal mucosa (control-CT). Quantitative analyses of all groups showed a greater expression of PCNA, followed by Ki-67 and cyclin B1. A significant difference was observed in cyclin B1 expression in the SCC group compared with VC. PCNA, Ki-67, and cyclin B1 were statistically significant when comparing the SCC and CT groups. However, when SCC and VC were compared, there was no difference in Ki-67 expression. Our results showed that only cyclin B1 had an association with histological grade, and that poorly differentiated tumors presented a higher expression of cyclin B1. Therefore, considerable differences in the cellular proliferation between SCC and VC were observed, and no correlation with HPV was established, since all samples were negative for HPV.

International Agency for Research on Cancer (IARC). http://screening.iarc.fr/oralindex.php?lang=1. Accessed on 25 May 2010.

Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery. 1948;23:670–8.PubMed

Oliveira DT, de Moraes RV, Fiamengui Filho JF, Fanton Neto J, Landman G, Kowalski LP. Oral verrucous carcinoma: a retrospective study in São Paulo Region, Brazil. Clin Oral Investig. 2006;10:205–9.CrossRefPubMed

Bouquot JE. Oral verrucous carcinoma. Incidence in two US populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:318–24.CrossRefPubMed

Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195–215.CrossRefPubMed

Spiro RH. Verrucous carcinoma, then and now. Am J Surg. 1998;176:393–7.CrossRefPubMed

Rajendran R, Varghese I, Sugathan CK, Vijayakumar T. Ackerman's tumour (verrucous carcinoma) of the oral cavity: a clinico-epidemiologic study of 426 cases. Aust Dent J. 1988;33:295–8.CrossRefPubMed

Rajendran R, Sugathan CK, Augustine J, Vasudevan DM, Vijayakumar T. Ackerman's tumour (verrucous carcinoma) of the oral cavity: a histopathologic study of 426 cases. Singapore Dent J. 1989;14:48–53.PubMed

Ferlito A, Devaney KO, Rinaldo A, Putzi MJ. Papillary squamous cell carcinoma versus verrucous squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108:318–22.PubMed

10.

Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, et al. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer. 2001;92:110–20.CrossRefPubMed

11.

Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67–76.CrossRefPubMed

12.

Brown LM. Epidemiology of alcohol-associated cancers. Alcohol. 2005;35:161–8.CrossRefPubMed

13.

Pintos J, Franco EL, Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case–control study. Int J Epidemiol. 1998;27:936–40.CrossRefPubMed

14.

Eisenberg E, Rosenberg B, Krutchkoff DJ. Verrucous carcinoma: a possible viral pathogenesis. Oral Surg Oral Med Oral Pathol. 1985;59:52–7.CrossRefPubMed

15.

Scully C. Oral cancer; the evidence for sexual transmission. Br Dent J. 2005;199:203–7.CrossRefPubMed

16.

Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983;12:418–24.CrossRefPubMed

17.

Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622–35.CrossRefPubMed

18.

Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the international Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–83.PubMed

19.

Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, et al. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol. 2004;40:736–41.CrossRefPubMed

20.

Lee SY, Cho NH, Choi EC, Baek SJ, Kim WS, Shin DH, et al. Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral Maxillofac Surg. 2010;39:678–83.CrossRefPubMed

21.

Campisi G, Giovannelli L. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol. 2009;30:8.CrossRef

22.

Huang B, Chen H, Fan M. A postulated role for human papillomavirus (HPV) in the transformation and proliferation of oral squamous cell carcinoma (OSCC). Med Hypotheses. 2008;70:1041–3.CrossRefPubMed

23.

Schliephake H. Prognostic relevance of molecular markers of oral cancer—a review. Int J Oral Maxillofac Surg. 2003;32:233–45.CrossRefPubMed

24.

Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res. 2001;7:2458–62.PubMed

25.

Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med. 1999;28:77–81.CrossRefPubMed

26.

Merne M, Heinaro I, Lähteenoja H, Syrjänen S. Proliferation and differentiation markers in snuff-induced oral mucosal lesions. J Oral Pathol Med. 2002;31:259–66.CrossRefPubMed

27.

Steinbeck RG, Moege J, Heselmeyer KM, Klebe W, Neugebauer W, Borg B, et al. DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions. Eur J Cancer B Oral Oncol. 1993;29B:279–84.CrossRefPubMed

28.

Costa Ade L, de Araujo NS, Pinto Ddos S, de Araujo VC. PCNA/AgNOR and Ki67/AgNOR double staining in oral squamous cell carcinoma. J Oral Pathol Med. 1999;28:438–41.CrossRefPubMed

29.

Saito T, Nakajimat T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999;28:226–32.CrossRefPubMed

30.

Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, et al. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med. 2005;34:602–7.CrossRefPubMed

31.

Drachenberg CB, Blanchaert R, Ioffe OB, Ord RA, Papadimitriou JC. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. Cancer Detect Prev. 1997;21:483–9.PubMed

32.

Tumuluri V, Thomas GA, Fraser IS. Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med. 2002;31:598–604.CrossRefPubMed

33.

González-Moles MA, Rodríguez-Archilla A, Ruiz-Avila I, González-Moles S, Marfil-Alvarez R. Increase of proliferating cell nuclear antigen (PCNA) expression in HPV-18 positive oral squamous cell carcinomas. Acta Stomatol Belg. 1996;93(3):113–8.PubMed

34.

World Health Organization. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin: Springer; 1997.

35.

Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S. Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene. 1994;9:3695–700.PubMed

36.

de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papilomavírus detection by PCR. J Gen Virol. 1995;76:1057–62.CrossRefPubMed

37.

Harada H, Omura K, Nakajima Y, Hasegawa S, Mogi S. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma. J Exp Clin Cancer Res. 2006;25:351–6.PubMed

38.

Ferlito A, Rinaldo A, Mannarà GM. Is primary radiotherapy an appropriate option for the treatment of verrucous carcinoma of the head and neck? J Laryngol Otol. 1998;112:132–9.PubMed

39.

Scully C, Félix DH. Oral medicine—update for the dental practitioner oral cancer. Br Dent J. 2006;14:13–7.CrossRef

40.

Demian SD, Bushkin FL, Echevarria RA. Perineural invasion and anaplastic transformation of verrucous carcinoma. Cancer. 1973;32:395–401.CrossRefPubMed

41.

van Diest PJ, Brugal G, Baak JP. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol. 1998;51(10):716–24.CrossRefPubMed

42.

Girod SC, Krueger G, Pape HD. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg. 1993;22:285–8.CrossRefPubMed

43.

Warnakulasuriya KA, Johnson NW. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med. 1994;23:246–50.CrossRefPubMed

44.

Pich A, Chiusa L, Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol. 2004;15:1319–29.CrossRefPubMed

45.

Watanabe S, Watanabe R, Oton-Leite AF, Alencar Rde C, Oliveira JC, Leles CR, et al. Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma. J Oral Sci. 2010;52:417–24.CrossRefPubMed

46.

Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr. 2003;31:80–8.

47.

Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol. 2008;46:1050–9.CrossRefPubMed

48.

Söderlund-Strand A, Carlson J, Dillner J. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol. 2009;47:541–6.CrossRefPubMed

49.

Rivero ER, Nunes FD. HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR. Braz Oral Res. 2006;20:21–4.CrossRefPubMed

50.

Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol. 2008;19:1681–90.CrossRefPubMed

51.

Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev. 2005;14:467–75.CrossRef

52.

Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009;3:78–81.CrossRefPubMed

53.

Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781–9.CrossRefPubMed

Titel: Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV)
verfasst von: José Vieira de Spíndula-Filho
Aparecido Divino da Cruz
Angélica Ferreira Oton-Leite
Aline Carvalho Batista
Cláudio Rodrigues Leles
Rita de Cássia Gonçalves Alencar
Vera Aparecida Saddi
Elismauro Francisco Mendonça
Publikationsdatum: 01.04.2011
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 2/2011
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-010-0135-4

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV)

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China

Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate

A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression

Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics

Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma

Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie